Boost for skin cancer patients after drug U-turn
Skin cancer patients given new hope after health watchdog recommends two life-extending treatments should be available on the NHS.
Read the full storyLive updates
Skin cancer patients offered lifeline
Skin cancer patients are being offered a lifeline after a u-turn on a drug trialled in the North West
The drug Yervoy was trialled at the Christie. Now the clinical group NICE has decided to make it available on the NHS. Patient groups have welcomed the decision.
Advertisement
Christie Hospital tests new breast cancer drug
A new breast cancer drug is being tested in Manchester, that could be a lifeline to women with the most aggressive form of the disease.
The drug, known as T-DM1, is designed to slow the progress of The treatment increases the survival time of some patients by almost six months.
It also reduces side effects such as hair loss, and gives sufferers a better quality of life
The Christie Hospital trials new breast cancer drug
A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
Today's top stories
